LipoNova AG: Local Supervisory Agency Approves Production license of LipoNova’s Early-Stage Kidney Cancer Vaccine Reniale®   ***   LipoNova AG reaches key milestones in the Reniale development process during 2007. Costs below budget.   ***   LipoNova signs memorandum of understanding for the marketing of Reniale®   ***   
Contact

Departments

General Requests

Telephone: +49 (0) 511 540 99-0
mail: info@liponova.de

Logistics and ongoing Coordination with Clinics

Ms. Patricia Leno
Telephone: +49 (0) 511 540 99-331
mail: patricia.leno@liponova.de



Accounts / payables

Ms. Karin Stolz
Telephone: + 49 (0) 511 540 99-611
mail: karin.stolz@liponova.de



Human Resources

Ms. Roselyne Ferchaud-Köß
Telephone: +49 (0) 511 540 99-124
mail: roselyne.ferchaud-koess@liponova.de

 

LipoNova AG
Medical Park
Feodor-Lynen-Str. 35
30625 Hannover

Telephone: +49 (0)511 540 990
Telefax:     +49 (0)511 540 9931
E-Mail: info@liponova.de
www.liponova.de